Post-COVID-19 Syndrome
Also known as: Post- COVID-19 Syndrome / Post COVID-19 Syndrome / Long COVID-19 / Post COVID-19 condition / Post-acute COVID-19 (disorder) / Post-Acute COVID-19 Syndrome / Post COVID-19 condition, unspecified / Long COVID
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00297 | Bupivacaine | 1 | Active Not Recruiting | 1 |
| DB15729 | Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins | 2 | Completed | 1 |
| DB00915 | Amantadine | 2 | Not Yet Recruiting | 1 |
| DB00959 | Methylprednisolone | 2 | Recruiting | 1 |
| DB14128 | Nadide | 2 | Completed | 1 |
| DB00704 | Naltrexone | 2 | Completed | 1 |
| DB16691 | Nirmatrelvir | 2 | Recruiting | 1 |
| DB00503 | Ritonavir | 2 | Recruiting | 1 |
| DB15634 | Temelimab | 2 | Active Not Recruiting | 1 |
| DB09068 | Vortioxetine | 2 | Completed | 1 |
| DB09357 | Dexpanthenol | 3 | Recruiting | 1 |
| DB03247 | Flavin mononucleotide | 3 | Recruiting | 1 |
| DB02701 | Nicotinamide | 3 | Recruiting | 1 |
| DB00860 | Prednisolone | 3 | Recruiting | 1 |
| DB00165 | Pyridoxine | 3 | Recruiting | 1 |
| DB00152 | Thiamine | 3 | Recruiting | 1 |
| DB00152 | Thiamine | 4 | Recruiting | 1 |
| DB15729 | Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins | Not Available | No Longer Available | 1 |
| DB01394 | Colchicine | Not Available | Completed | 1 |
| DB04951 | Pirfenidone | Not Available | Completed | 1 |